Q4 Results: Cipla Expects Margin To Improve In FY20
A technician inspects vaccine vials for defects at a pharmaceutical plant in Pune. (Photographer: Sanjit Das/Bloomberg)

Q4 Results: Cipla Expects Margin To Improve In FY20

Bookmark
Cipla Ltd. is confident of improving its margin in financial year 2019-20 as the drugmaker eyes timely launch of its drugs in the U.S.“The margin expansion would be driven by a changing mix in Cipl...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.